secwatch.observer — SEC 8-K summary
======================================

Issuer:     NextCure, Inc. (NXTC)
CIK:        0001661059
Form:       8-K
Filed at:   2025-11-17T23:59:59+00:00
Accession:  0001104659-25-112975
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 3.02, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NextCure closes $21.5M PIPE led by Ikarian, Squadron; extends cash runway into H1 2027
--------------------------------------------------------------------------------

- Gross proceeds of ~$21.5M from PIPE closed Nov 14, 2025; 708,428 shares at $8.52 and 1,815,049 pre-funded warrants at $8.519.
- Lead investors: Ikarian Capital, Squadron Capital Management, Affinity Healthcare Fund, Exome Asset Management; H.C. Wainwright placement agent.
- Cash runway extended into H1 2027, beyond planned H1 2026 POC data readouts for SIM0505 (CDH6 ADC) and LNCB74 (B7-H4 ADC).
- Registration rights agreement entered to file resale registration statement with SEC for the sold securities.
- Management believes existing cash, equivalents, and marketable securities sufficient to fund operations into first half of 2027.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1661059/000110465925112975/0001104659-25-112975-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1661059/000110465925112975/nxtc-20251112x8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-112975

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer